Apoptosis as a pathomechanism in sepsis;Apoptose als Pathomechanismus in der Sepsis

Anaesthesist

Volumn 53, Issue 1, 2004, Pages 59-65

  Weber, S U ^a,b   Schewe, J C ^a   Putensen, C ^a   Stuber F ^a   Schroder S ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Apoptosis; Bcl 2; Fas; Mitochondrium; Sepsis

Indexed keywords

CASPASE; MITOCHONDRIAL PROTEIN; PROTEIN BCL 2;

ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL STRUCTURE; CYTOLOGY; DISEASE SEVERITY; ENZYME INHIBITION; EPIDEMIOLOGICAL DATA; GASTROINTESTINAL TRACT; GENE OVEREXPRESSION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; LEUKOCYTE; NONHUMAN; PATHOPHYSIOLOGY; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL RATE; UPREGULATION;

ANIMALS; APOPTOSIS; HUMANS; SEPSIS; SIGNAL TRANSDUCTION;

EID: 1042291100     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-003-0627-3     Document Type: Article

References (70)

1. Adrie C, Bachelet M, Vayssier-Taussat M et al. (2001) Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med 164:389-395
2. Anderson HA, Maylock CA, Williams JA, Paweletz CP, Shu H, Shacter E (2003) Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 4:87-91
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310
4. Aranow JS, Fink MP (1996) Determinants of intestinal barrier failure in critical illness. Br J Anaesth 77:71-81
5. Ayala A, Herdon CD, Lehman DL, Ayala CA, Chaudry IH (1996) Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87:4261 -4275
6. Ayala A, Xin XY, Ayala CA, Sonefeld DE, Karr SM, Evans TA, Chaudry IH (1998) Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood 91:1362-1372
7. Ayala A, Chung CS, Xu YX, Evans TA, Redmond KM, Chaudry IH (1999) Increased inducible apoptosis in CD4+ T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin. Immunology 97:45-55
8. Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331-335
9. Bone RC (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24:1125-1128
10. Bone RC, Balk RA, Cerra FB et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655
11. Brun-Buisson C (2000) The epidemiology of the systemic inflammatory response. Intensive Care Med 26 [Suppl 1]:S64-74
12. Brun-Buisson C, Doyon F, Carlet J et al. (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 274:968-974
13. Buendia B, Santa-Maria A, Courvalin JC (1999) Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis. J Cell Sci 112:1743-1753
14. Bump NJ, Hackett M, Hugunin M et al. (1995) Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269:1885-1888
15. Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771-778
16. Chung CS, Xu YX, Chaudry IH, Ayala A (1998) Sepsis induces increased apoptosis in lamina propria mononuclear cells which is associated with altered cytokine gene expression. J Surg Res 77:63-70
17. Chung CS, Song GY, Moldawer LL, Chaudry IH, Ayala A (2000) Neither Fas ligand nor endotoxin is responsible for inducible peritoneal phagocyte apoptosis during sepsis/peritonitis. J Surg Res 91:147-153
18. Coopersmith CM, Chang KC, Swanson PE et al. (2002) Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice. Crit Care Med 30:19S-201
19. Coopersmith CM, Stromberg PE, Dunne WM et al. (2002) Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287:1716-1721
20. Daugas E, Nochy D, Ravagnan L, Loeffler M, Susin SA, Zamzami N, Kroemer G (2000) Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 476:118-123
21. Deitch EA, Bridges W, Baker J et al. (1988) Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation. Surgery 104:191-198
22. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50
23. Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342-348
24. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM (1998) The role of phosphatidylserinein recognition of apoptoticcells by phagocytes. Cell Death Differ 5:551-562
25. Frasch SC, Henson PM, Kailey JM, Richter DA, Janes MS, Fadok VA, Bratton DL (2000) Regulation of phospholipld scramblase activity during apoptosis and cell activation by protein kinase Cdelta. J Biol Chem 275:23065-23073
26. Green DR, Ferguson TA (2001 ) The role of Fas ligand in immune privilege. Nat Rev Mol Cell Biol 2:917-924
27. Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770-776
28. Hersey P, Zhang XD (2001) How melanoma cells evade trail-induced apoptosis. Nat Rev Cancer 1:142-150
29. Hiramatsu M, Hotchkiss RS, Karl IE, Buchman TG (1997) Cecal ligation and puncture (CLP) induces apoptosis in thymus, spleen, lung, and gut by an endotoxin and TNF-independent pathway. Shock 7:247-253
30. Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348:138-150
31. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE (1997) Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T-and B-cell-deficient mice. Crit Care Med 25:1298-1307
32. Hotchkiss RS, Swanson PE, Freeman BD et al. (1999) Apoptotic cell death In patients with sepsis, shock, and multiple organ dysfunction.Crit Care Med 27:1230-1251
33. Hotchkiss RS, Swanson PE, Knudson CM et al. (1999) Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 162:4148-4156
34. Hotchkiss RS, Tinsley KW, Swanson PE et al. (1999) Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A 96:14541-14546
35. Hotchkiss RS, Tinsley KW, Hui JJ et al. (2000) p53-dependent and -independent pathways of apoptotic cell death in sepsis. J Immunol 164:3675-3680
36. Hotchkiss RS, Chang KC, Swanson PE et al. (2000) Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 1:496-501
37. Hotchkiss RS, Tinsley KW, Swanson PE et al. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 166:6952-6963
38. Hotchkiss RS, Tinsley KW, Swanson PE et al. (2002) Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 168:2493-2500
39. Hotchkiss RS, Tinsley KW, Swanson PE, Karl IE (2002) Endothelial cell apoptosis in sepsis. Crit Care Med 30:S225-228
40. Johnson DE (2000) Noncaspase proteases in apoptosis. Leukemia 14:1695-1703
41. Kerr JF (1971 ) Shrinkage necrosis: a distinct mode of cellular death. J Pathol 105:13-20
42. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
43. Kothakota S, Azuma T, Reinhard C et al. (1997) Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278:294-298
44. Kox WJ, Volk T, Kox SN, Volk HD(2000) Immunomodulatory therapies in sepsis. Intensive Care Med 26 [Suppl 1]:S124-128
45. Krammer PH (2000) CD95's deadly mission in the immune system. Nature 407:789-795
46. Leist M, Jaattela M (2001) Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2:589-598
47. Levy MM, Fink MP, Marshall JC et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250-1256
48. Liu X, Zou H, Slaughter C, Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89:175-184
49. Maloney JP, Halbower AC, Fouty BF et al. (2000) Systemic absorption of food dye in patients with sepsis. N Engl J Med 343:1047-1048
50. Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL (1997) Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med 25:1813-1819
51. Martinou JC, Green DR (2001 ) Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2:63-67
52. Mate MJ, Ortiz-Lombardia M, Boitel B et al. (2002) The crystal structure of the mouse apoptosis-inducing factor AIF. Nat Struct Biol 9:442-446
53. Meier P, Finch A, Evan G (2000) Apoptosis in development. Nature 407:796-801
54. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J (1993) Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.Cell 75:653-660
55. Nicholson DW (2000) From bench to clinic with apoptosis-based therapeutic agents. Nature 407:810-816
56. Oberholzer A, Oberholzer C, Minter RM, Moldawer LL (2001 ) Considering immunomodulatory therapies in the septic patient: should apoptosis be a potential therapeutic target? Immunol Lett 75:221-224
57. Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL (2001) Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J 15:879-892
58. Papathanassoglou ED, Moynihan JA, McDermott MP, Ackerman MH (2001 ) Expression of Fas (CD9S) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival. Crit Care Med 29:709-718
59. Reed JC (2002) Apoptosis-based therapies. Nat Rev Drug Discov 1:111-121
60. Reinhart K, Karzai W (2001 ) Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med 29:S121-125
61. Salvesen GS, Duckett CS (2002) IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3:401-410
62. Schroeder S, Lindemann C, Decker D et al. (2001) Increased susceptibility to apoptosis in circulating lymphocytes of critically ill patients. Langenbecks Arch Surg 386:42-46
63. Susin SA, Lorenzo HK, Zamzami N et al. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397:441-446
64. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312-1316
65. Tinsley KW, Cheng SL, Buchman TG et al. (2000) Caspases-2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis. Shock 13:1-7
66. Walmrath D, Grimminger F, Seeger W (2001) Schwere Sepsis - neue Therapieverfahren. Internist 42:1619-1630
67. Wang SD, Huang KJ, Lin YS, Lei HY (1994) Sepsis-induced apoptosis of the thymocytes in mice. J Immunol 152:5014-5021
68. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556
69. Xiang J, Chao DT, Korsmeyer SJ ( 1996) BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci U S A 93:14559-14563
70. Zamzami N, Kroemer G (2001) The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2:67-71